Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2024-12-03 to 2026-11-04
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
bit.bio A human cell programming company developing technology to produce consistent, scalable human cell models for drug discovery, disease research, functional genomics and toxicology. | Series D Verified against 4 of 9 sources | $25M | 2026-11-04 | [ PART ] |
52North A University of Cambridge medtech spinout | Growth Developing, 4 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $6.0M | 2024-12-03 | [ PART ] |